HHT

8 registered clinical trials studyying HHT — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Institutional Registry of Rare Diseases NCT06573723	Hospital Italiano de Buenos Aires	—
Active Not Recruiting	Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) NCT03850964	Cure HHT	Phase 2 / Phase 3
Completed	Subsequent Bevacizumab Treatment in Patients With HHT. Follow up BABH NCT06039124	Hospices Civils de Lyon	—
Completed	Genotype-phenotype Association in Hereditary Hemorrhagic Telangiectasia NCT05550376	Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal	—
Active Not Recruiting	Tourniquet-Test in HHT NCT06266624	University Hospital, Essen	N/A
Active Not Recruiting	CHORUS - Comprehensive HHT Outcomes Registry of the United States (Formerly OUR HHT Registry) NCT04150822	Unity Health Toronto	—
Completed	Intranasal Bevacizumab for HHT-Related Epistaxis NCT02389959	Stanford University	Phase 4
Completed	Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) NCT01314274	Medical University of Vienna	Phase 2